K190338 · Inneuroco, Inc. · NRY · Aug 2, 2019 · Cardiovascular
Device Facts
Record ID
K190338
Device Name
046 Zenith Flex
Applicant
Inneuroco, Inc.
Product Code
NRY · Cardiovascular
Decision Date
Aug 2, 2019
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1250
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The Zenith Flex Aspiration System, including the 046 Zenith Flex Catheter, Aspiration Tubing Set, and VC-701 Cliq Aspirator Pump, is indicated in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who failed IV t-PA therapy are candidates for treatment.
Device Story
System for mechanical aspiration thrombectomy in acute ischemic stroke. Components: 046 Zenith Flex Catheter, Aspiration Tubing Set, VC-701 Cliq Aspirator Pump. Catheter: variable stiffness, Nitinol-reinforced shaft, PTFE-lined lumen, hydrophilic coating, radiopaque marker band. Used in neurointerventional procedures by physicians. Catheter tracks over guidewire to occlusion site; pump provides vacuum aspiration (22-28 in Hg) to remove thrombi. Output: revascularization of occluded intracranial vessels. Benefits: restores blood flow in stroke patients. Device is sterile, single-use (catheter/tubing), non-sterile, multi-use (pump).
Clinical Evidence
No clinical study conducted. Substantial equivalence supported by bench testing (biocompatibility, mechanical, performance, sterilization, shelf-life) and animal testing (swine model, 3-day/30-day follow-up, angiographic/histopathological assessment). Literature review of predicate and similar devices supported clinical outcomes.
Indicated for revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (internal carotid, M1/M2 middle cerebral, basilar, and vertebral arteries) within 8 hours of symptom onset. Candidates include patients ineligible for or failed IV t-PA therapy.
Regulatory Classification
Identification
A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.
K172167 — Zenith Flex System · Inneuroco, Inc. · Apr 19, 2018
K251006 — NeVasc Aspiration System · Vesalio, Inc. · Nov 10, 2025
K233329 — Route 92 Medical Full Length 054 Reperfusion System and Aspiration Tubing Set · Route 92 Medical, Inc. · Apr 23, 2024
K223530 — Route 92 Medical Full Length 070 Reperfusion System and Aspiration Tubing Set · Route 92 Medical, Inc. · Apr 11, 2023
K243601 — Route 92 Medical HiPoint Reperfusion System and Aspiration Tubing Set · Route 92 Medical, Inc. · May 19, 2025
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food & Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text.
August 2, 2019
InNeuroCo, Inc. Marianne Grunwaldt Director, Quality Assurance and Regulatory Affairs 4635 NW 103rd Avenue Sunrise, Florida 33351
Re: K190338
Trade/Device Name: Zenith Flex Aspiration System (046 Zenith Flex Catheter) Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: NRY Dated: July 3, 2019 Received: July 5, 2019
Dear Marianne Grunwaldt:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Xiaolin Zheng, Ph.D. Assistant Director DHT5A: Division of Neurosurgical, Neurointerventional and Neurodiagnostic Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K190338
Device Name
Zenith Flex Aspiration System (046 Zenith Flex Catheter)
Indications for Use (Describe)
The Zenith Flex Aspiration System, including the 046 Zenith Flex Catheter, Aspiration Tubing Set, and VC-701 Cliq Aspirator Pump, is indicated in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who failed IV t-PA therapy are candidates for treatment.
| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------|---------------------------------------------|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
#### 510(k) SUMMARY
#### Submitter's Name and Address:
InNeuroCo, Inc. 4635 NW 103rd Avenue Sunrise, Florida 33351 Telephone: 1-954-742-5988 Facsimile: 1-954-742-5989
#### Contact Information:
Marianne Grunwaldt Director, Quality Assurance & Regulatory Affairs InNeuroCo, Inc 4635 NW 103rd Avenue Sunrise, Florida 33351 Telephone: 1-954-703-5271 Facsimile: 1-954-742-5989 E-Mail: Marianne@InNeuroCo.com
#### Secondary Contact:
Ming Cheng Chew Regulatory Consultant, Libra Medical, Inc. 8401 73rd Ave N, Suite 63 Brooklyn Park, MN 55428 Telephone: 763-232-3701 E-Mail: mcchew@libramed.com
# Date Prepared
February 12, 2019
## Device Trade or Proprietary Name Zenith Flex Aspiration System (046 Zenith Flex Catheter)
# Device Common or Classification Name:
Catheter, Percutaneous, 21 CFR 870.1250, Class II
Product Code: NRY (Catheter)
{4}------------------------------------------------
### Identification of the Legally Marketed Devices to which Equivalence is Being Claimed
| Name of Predicate Device | Name of Manufacturer | 510(k) Number |
|--------------------------|----------------------|---------------|
| 3 Max | Penumbra | K113163 |
### Identification of the Legally Marketed Device used as the Reference Device
| Name of Reference Device | Name of Manufacturer | 510(k) Number |
|-----------------------------------------|----------------------|---------------|
| Zenith Flex System<br>(071 Zenith Flex) | InNeuroCo, Inc | K172167 |
## Device Description
The InNeuroCo 046 Zenith Flex Catheter is a variable stiffness catheter that has a catheter shaft reinforced with Nitinol to provide support. The proximal section has an embedded nitinol flat wire cross coil that transitions to a nitinol round wire sinqle coil in the distal end. It has a radiopaque Platinum/Iridium marker band on the distal end. The 046 Zenith Flex Catheter is available with an internal diameter of 0.046 inches. The outer diameter is 0.058 inches along the proximal shaft and 0.056 inches at the distal tip. The 046 Zenith Flex Catheter is available in two working lengths: 153 cm, and 160 cm. The 046 Zenith Flex Catheter has a PTFE-lined lumen to reduce friction as it travels over a guidewire. Accessories included with the device are a Tuohy-Borst Hemostasis Valve and peel-away introducer. The 046 Zenith Flex Catheter is supplied sterile, non-pyrogenic, and intended for single use only.
The other system components are: the Aspiration Tubinq Set and the VC-701 Cliq Aspirator Pump. The Aspiration Tubing Set is provided sterile and is intended for single use only. The aspiration pump is provided non-sterile and is used in multiple procedures.
#### Indications for Use
The Zenith Flex Aspiration System, including the 046 Zenith Flex Catheter, Aspiration Tubing Set, and VC-701 Cliq Aspirator Pump, is indicated in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 seqments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who failed IV t-PA therapy are candidates for treatment.
{5}------------------------------------------------
# Comparison to Predicate Device
| | Predicate Device<br>Penumbra 3 Max | Subject Device<br>InNeuroCo, Inc.<br>046 Zenith Flex Catheter |
|---------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Number | K113163 | K190338 |
| Classification | Class II | Same |
| Product Code | NRY | Same |
| Review Panel | Neurology | Same |
| Indications For<br>Use | The Penumbra System is intended<br>for use in the revascularization of<br>patients with acute ischemic stroke<br>secondary to intracranial large<br>vessel occlusive disease (in the<br>internal carotid, middle cerebral -<br>M1 and M2 segments, basilar, and<br>vertebral arteries) within 8 hours of<br>symptom onset. | The Zenith Flex Aspiration System,<br>including the 046 Zenith Flex<br>Catheter, Aspiration Tubing Set, and<br>VC-701 Cliq Aspirator Pump, is<br>indicated in the revascularization of<br>patients with acute ischemic stroke<br>secondary to intracranial large<br>vessel occlusive disease (within the<br>internal carotid, middle cerebral<br>– M1 and M2 segments, basilar,<br>and vertebral arteries) within 8<br>hours of symptom onset. Patients<br>who are ineligible for intravenous<br>tissue plasminogen activator (IV t-<br>PA) or who failed IV t-PA therapy<br>are candidates for treatment. |
| Components<br>Supplied in the<br>catheter package | 3Max Reperfusion Catheter, | 046 Zenith Flex Catheter, Peel<br>Away Introducer, Hemostasis<br>Valve |
| System<br>components | Catheter, Pump, Aspiration Tubing | Same |
| Catheter Shaft<br>Material | Polyether Block Amide (PEBAX),<br>Urethane, Nylon | Same |
| Inner Liner | PTFE | Same |
| Hub Material | Polycarbonate | Same |
| Strain Relief | Stainless Steel | Polyolefin |
| Catheter Shaft<br>Reinforcement | Stainless Steel/Nitinol | Same |
| Reinforcement<br>pattern | Coil | Same |
| Lubricious<br>Coating | Hydrophilic Coating | Same |
| Radiopaque<br>Marker Band | Platinum/ Iridium | Same |
| Catheter<br>Packaging | Tyvek/Nylon Pouch, polyethylene<br>support tube, packaging card,<br>carton | Same |
| Sterilization | Ethylene Oxide | Same |
| Pyrogenicity | Nonpyrogenic | Same |
| Working Lengths | 153 cm, 160 cm | Same |
| Inside Diameter<br>(ID) | 0.043 in distal<br>0.035 in proximal | 0.046 in |
| Proximal Outer<br>Diameter | 0.062 in | 0.058 in |
| Distal Outer<br>Diameter | 0.050 in nominal | 0.056 in |
| Introducer | Peelaway to aid in catheter tip<br>introduction into hemostasis valve | Peelaway to aid in catheter tip<br>introduction into hemostasis valve |
| Hemostasis Valve | Yes | Same |
| Luer Tapered Hub | Yes | Same |
| Aspiration Method | Pump | Same |
| Aspiration<br>Pressure | 20-29 in Hg | 22-28 in Hg |
| | Reference Device<br>InNeuroCo, Inc.<br>071 Zenith Flex | Subject Device<br>InNeuroCo, Inc.<br>046 Zenith Flex Catheter |
| 510(k) Number | K172167 | K190338 |
| Classification | Class II | Same |
| Product Code | NRY | Same |
| Review Panel | Neurology | Same |
| Indications For<br>Use | The Zenith Flex Aspiration System,<br>including the Zenith Flex Catheter,<br>Aspiration Tubing Set, and VC-701<br>Cliq Aspirator Pump, is indicated in<br>the revascularization of patients<br>with acute ischemic stroke<br>secondary to intracranial large<br>vessel occlusive disease (within<br>the internal carotid, middle cerebral<br>- M1 and M2 segments, basilar,<br>and vertebral arteries) within 8<br>hours of symptom onset. Patients<br>who are ineligible for intravenous<br>tissue plasminogen activator (IV t-<br>PA) or who failed IV t-PA therapy<br>are candidates for treatment. | Same |
| Components<br>Supplied in the<br>catheter package | Zenith Flex Catheter, Peel Away<br>Introducer, Hemostasis Valve,<br>Scout Introducer | 046 Zenith Flex Catheter, Peel<br>Away Introducer, Hemostasis<br>Valve |
| System<br>components | Catheter, Pump, Aspiration Tubing | Same |
| Catheter Shaft<br>Material | Polyether Block Amide (PEBAX),<br>Urethane, Nylon | Same |
| Inner Liner | PTFE | Same |
| Hub Material | Polycarbonate | Same |
| Strain Relief | Polyolefin | Same |
| Catheter Shaft<br>Reinforcement | Stainless Steel/Nitinol | Same |
| Reinforcement<br>pattern | Coil | Same |
| Lubricious<br>Coating | Hydrophilic Coating | Same |
| Radiopaque<br>Marker Band | Platinum/ Iridium | Same |
| Catheter<br>Packaging | Tyvek/Nylon Pouch, polyethylene<br>support tube, packaging card, SBS<br>carton | Same |
| Sterilization | Ethylene Oxide | Same |
| Pyrogenicity | Nonpyrogenic | Same |
| Working Lengths | 115, 125, 132 cm | 153 cm, 160 cm |
| Inside Diameter<br>(ID) | 0.071 in | 0.046 in |
| Proximal Outer<br>Diameter | 0.085 in | 0.058 in |
| Distal Outer<br>Diameter | 0.082 in nominal | 0.056 in |
| Introducer | Peelaway to aid in catheter tip<br>introduction into hemostasis valve<br>Scout to help with the navigation | Peelaway to aid in catheter tip<br>introduction into hemostasis valve |
| Hemostasis Valve | Yes | Same |
| Luer Tapered Hub | Yes | Same |
| Aspiration Method | Pump | Same |
| Aspiration<br>Pressure | 22-28 in Hg | Same…
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.